Abstract
Carlos Arteaga, MD; Steven D. Leach, MD; and Paul M. Harari, MD, are highlighted.
Breast cancer expert Carlos Arteaga, MD, began his new role as director of the Harold C. Simmons Comprehensive Cancer Center at The University of Texas Southwestern Medical Center in Dallas on September 1. Previously, Arteaga served as the director of the Center for Cancer Targeted Therapies, director of the breast cancer program, and associate director for translational and clinical research at the Vanderbilt-Ingram Cancer Center in Nashville, TN. A former president of the American Association for Cancer Research, Arteaga's research interests include gene signaling, molecular therapeutics, and drug resistance in breast cancer.
This month, Steven D. Leach, MD, will begin work as the director of the Norris Cotton Cancer Center at Dartmouth in Lebanon, NH. Most recently, Leach directed the Rubenstein Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer Center in New York, NY. He has pursued multiple avenues of research on the disease, such as the mechanisms of development, the ability of molecular profiling to direct patient treatment, and the creation of organoid models to identify molecular pathways that correlate with the progression of pancreatic cancer.
Paul M. Harari, MD, director of the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health and the Carbone Cancer Center in Madison, will begin a 1-year term as president of the American Society for Radiation Oncology at the organization's annual meeting in San Diego, CA, at the end of the month. His research focuses on the treatment of head and neck cancer and how molecular signaling pathways can modulate tumor response to radiation.
For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.